These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding? Mancini GB; Stewart DJ Can J Cardiol; 2001 May; 17 Suppl A():15A-7A. PubMed ID: 11381289 [TBL] [Abstract][Full Text] [Related]
3. Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Gerstein HC Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357 [TBL] [Abstract][Full Text] [Related]
4. [How should ACE inhibitors be used in myocardial infarction?]. Reikvam A; Madsen S Tidsskr Nor Laegeforen; 2000 Nov; 120(28):3413-7. PubMed ID: 11187196 [TBL] [Abstract][Full Text] [Related]
5. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836 [TBL] [Abstract][Full Text] [Related]
6. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences. McQueen MJ; Lonn E; Gerstein HC; Bosch J; Yusuf S Scand J Clin Lab Invest Suppl; 2005; 240():143-56. PubMed ID: 16112972 [TBL] [Abstract][Full Text] [Related]
7. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Gerstein HC Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
10. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction? Tu K; Gunraj N; Mamdani M Am J Cardiol; 2006 Jul; 98(1):6-9. PubMed ID: 16784910 [TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors reduce heart-related death in type 2 diabetics. Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126 [No Abstract] [Full Text] [Related]
12. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. Rapezzi C; Ciliberti P; Graziosi M; Riva L Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516 [TBL] [Abstract][Full Text] [Related]
14. [New indications. ACE inhibitor is now included in coronary heart disease therapy]. MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422714 [No Abstract] [Full Text] [Related]
15. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibitors: new hope for old drugs? Dvorak SR S D J Med; 2000 Aug; 53(8):333-4. PubMed ID: 10967940 [No Abstract] [Full Text] [Related]
18. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys]. MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601 [No Abstract] [Full Text] [Related]
19. [The HOPE Study. What does it contribute to general practice?]. Mann J; Sleight P MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776 [TBL] [Abstract][Full Text] [Related]
20. The HOPE Study (Heart Outcomes Prevention Evaluation). Sleight P J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]